Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells

References

• Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. 2023. Global burden of liver disease: 2023 update. J Hepatol. 79(2):516–11. doi: 10.1016/j.jhep.2023.03.017.
   PubMed Web of Science ®Google Scholar
• Montironi C, Castet F, Haber PK, Pinyol R, Torres-Martin M, Torrens L, Mesropian A, Wang H, Puigvehi M, Maeda M, et al. 2023. Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut. 72(1):129–140. doi: 10.1136/gutjnl-2021-325918.
   PubMed Web of Science ®Google Scholar
• Itoh S, Yoshizumi T, Yugawa K, Imai D, Yoshiya S, Takeishi K, Toshima T, Harada N, Ikegami T, Soejima Y, et al. 2020. Impact of immune response on outcomes in hepatocellular carcinoma: association with vascular formation. hepatology. 72(6):1987–1999. doi: 10.1002/hep.31206.
   PubMed Web of Science ®Google Scholar
• Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, Zhang W, Hsu C-H, He AR, Ryoo B-Y, et al. 2022. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat Med. 28(8):1599–1611. doi: 10.1038/s41591-022-01868-2.
   PubMed Web of Science ®Google Scholar
• Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, et al. 2019. Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Cancer Cell. 35(6):885–900.e810. doi: 10.1016/j.ccell.2019.05.004.
   PubMed Web of Science ®Google Scholar
• Sutherland TE, Dyer DP, Allen JE. 2023. The extracellular matrix and the immune system: a mutually dependent relationship. Sci. 379(6633):eabp8964. doi: 10.1126/science.abp8964.
   PubMed Web of Science ®Google Scholar
• Gaylo-Moynihan A, Prizant H, Popović M, Fernandes NRJ, Anderson CS, Chiou KK, Bell H, Bell H, Schrock DC, Schumacher J, et al. 2019. Programming of distinct chemokine-dependent and -Independent search strategies for Th1 and Th2 cells optimizes function at inflamed sites. Immunity. 51(2):298–309.e296. doi: 10.1016/j.immuni.2019.06.026.
   PubMed Web of Science ®Google Scholar
• Sun F, Wang J, Sun Q, Li F, Gao H, Xu L, Zhang J, Sun X, Tian Y, Zhao Q, et al. 2019. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 38(1):449. doi: 10.1186/s13046-019-1455-x.
   PubMed Web of Science ®Google Scholar
• Tucci M, Stucci S, Silvestris F. 2014. Does cilengitide deserve another chance? Lancet Oncol. 15(13):e584–e585. doi: 10.1016/S1470-2045(14)70462-0.
   PubMed Web of Science ®Google Scholar
• Wong PP, Muñoz-Félix JM, Hijazi M, Kim H, Robinson SD, De Luxán-Delgado B, Rodríguez-Hernández I, Maiques O, Meng YM, Meng Q, Bodrug N, et al. 2020. Cancer burden is controlled by mural cell-β3-integrin regulated crosstalk with tumor cells. Cell. 181(6):1346–1363.e1321. doi: 10.1016/j.cell.2020.02.003.
   PubMed Web of Science ®Google Scholar
• Su X, Esser AK, Amend SR, Xiang J, Xu Y, Ross MH, Fox GC, Kobayashi T, Steri V, Roomp K, et al. 2016. Antagonizing Integrin β3 Increases Immunosuppression in Cancer. Cancer Res. 76(12):3484–3495. doi: 10.1158/0008-5472.CAN-15-2663.
   PubMed Web of Science ®Google Scholar
• Larochelle C, Uphaus T, Broux B, Gowing E, Paterka M, Michel L, Dudvarski Stankovic N, Bicker F, Lemaître F, Prat A, et al. 2018. EGFL7 reduces CNS inflammation in mouse. Nat Commun. 9(1):819. doi: 10.1038/s41467-018-03186-z.
   PubMedGoogle Scholar
• Cai J, Wang J, Jiang C, Ye L, He X, Huang J, Sun X, Ren Z, Lai X, Qiu Y, et al. 2023. Combined inhibition of surface CD51 and γ-secretase-mediated CD51 cleavage improves therapeutic efficacy in experimental metastatic hepatocellular carcinoma. J Hepatol. 79(6):1418–1434. doi: 10.1016/j.jhep.2023.08.007.
   PubMed Web of Science ®Google Scholar
• Goehrig D, Nigri J, Samain R, Wu Z, Cappello P, Gabiane G, Zhang X, Zhao Y, Kim I-S, Chanal M, et al. 2019. Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer. Gut. 68(4):693–707. doi: 10.1136/gutjnl-2018-317570.
   PubMed Web of Science ®Google Scholar
• Du F, Garg AV, Kosar K, Majumder S, Kugler DG, Mir GH, Maggio M, Henkel M, Lacy-Hulbert A, McGeachy M, et al. 2016. Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function. Cell Rep. 16(5):1339–1351. doi: 10.1016/j.celrep.2016.06.065.
   PubMed Web of Science ®Google Scholar
• Dieffenbach PB, Mallarino Haeger C, Rehman R, Corcoran AM, Coronata AMF, Vellarikkal SK, Chrobak I, Waxman AB, Vitali SH, Sholl LM, et al. 2021. A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature. Am J Respir Crit Care Med. 204(12):1433–1451. doi: 10.1164/rccm.202108-1863OC.
   PubMed Web of Science ®Google Scholar
• Weisz A, Abadi U, Mausbach L, Gurwitz D, Ellis M, Ashur-Fabian O. 2022. Nuclear αvβ3 integrin expression, post translational modifications and regulation in hematological malignancies. Hematol Oncol. 40(1):72–81. doi: 10.1002/hon.2927.
   PubMed Web of Science ®Google Scholar
• Overstreet MG, Gaylo A, Angermann BR, Hughson A, Hyun YM, Lambert K, Acharya M, Billroth-MacLurg AC, Rosenberg AF, Topham DJ, et al. 2013. Inflammation-induced interstitial migration of effector CD4+ T cells is dependent on integrin αV. Nat Immunol. 14(9):949–958. doi: 10.1038/ni.2682.
   PubMed Web of Science ®Google Scholar
• Liu J, Guo Y, Zhang R, Xu Y, Luo C, Wang R, Xu S, et al. 2023. Inhibition of TRPV4 remodels single cell polarity and suppresses the metastasis of hepatocellular carcinoma. Cell Death Disease. 14(6):379. doi: 10.1038/s41419-023-05903-z.
   PubMed Web of Science ®Google Scholar
• Huang D, Cao L, Xiao L, Song JX, Zhang YJ, Zheng P, Zheng SG. 2019. Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma. Cancer Lett. 448:117–127. doi: 10.1016/j.canlet.2019.01.042.
   PubMed Web of Science ®Google Scholar
• Tan S, Li S, Min Y, Gisterå A, Moruzzi N, Zhang J, Sun Y, Andersson J, Malmström RE, Wang M, et al. 2020. Platelet factor 4 enhances CD4+ T effector memory cell responses via akt-PGC1α-TFAM signaling-mediated mitochondrial biogenesis. J Thromb Haemost. 18(10):2685–2700. doi: 10.1111/jth.15005.
   PubMed Web of Science ®Google Scholar
• La Manna MP, Orlando V, Badami GD, Tamburini B, Shekarkar Azgomi M, Lo Presti E, Del Nonno F, Petrone L, Belmonte B, Falasca L, et al. 2022. Platelets accumulate in lung lesions of tuberculosis patients and inhibit T-cell responses and mycobacterium tuberculosis replication in macrophages. Eur J Immunol. 52(5):784–799. doi: 10.1002/eji.202149549.
   PubMed Web of Science ®Google Scholar
• Scherlinger M, Guillotin V, Douchet I, Vacher P, Boizard-Moracchini A, Guegan JP, Garreau A, Merillon N, Vermorel A, Ribeiro E, et al. 2021. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Sci Transl Med. 13(600):eabi4994. doi: 10.1126/scitranslmed.abi4994.
   PubMed Web of Science ®Google Scholar
• Ma C, Fu Q, Diggs LP, McVey JC, McCallen J, Wabitsch S, Ruf B, et al. 2022. Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD. Cancer Cell. 40(9):986–998.e985. doi: 10.1016/j.ccell.2022.08.004.
   PubMed Web of Science ®Google Scholar
• Qu M, Zou X, Fang F, Wang S, Xu L, Zeng Q, Fan Z, Chen L, Yue W, Xie X, et al. 2020. Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p. Nat Commun. 11(1):4964. doi: 10.1038/s41467-020-18802-0.
   PubMed Web of Science ®Google Scholar